Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US
    Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US
    • News

  • June 2025 quarter CPI no roadblock to August RBA rate cut
    June 2025 quarter CPI no roadblock to August RBA rate cut
    • News

  • Vection Secures $7.3M Defence Extension as AI Demand Strengthens
    Vection Secures $7.3M Defence Extension as AI Demand Strengthens
    • News

  • Calix Secures $44.9m ARENA Grant to Build Green Iron Plant with ZESTY Technology
    Calix Secures $44.9m ARENA Grant to Build Green Iron Plant with ZESTY Technology
    • News

  • Harris Technology boosts retail margins in FY25 through growth of refurbished tech
    Harris Technology boosts retail margins in FY25 through growth of refurbished tech
    • News

  • Lumos Diagnostics Secures US$317M Deal to Distribute FebriDx® in U.S.
    Lumos Diagnostics Secures US$317M Deal to Distribute FebriDx® in U.S.
    • News

  • dorsaVi Powers Ahead with High-Speed RRAM for Smarter Wearables and Edge AI
    dorsaVi Powers Ahead with High-Speed RRAM for Smarter Wearables and Edge AI
    • News

  • Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    • News

  • Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    • News

  • EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    • News

Will fears of the Wuhan Coronavirus continue to hamstring markets?

  • In Opinion
  • February 5, 2020
  • Sam Green
Will fears of the Wuhan Coronavirus continue to hamstring markets?

Today the Chinese Government announced that the number of Wuhan coronavirus infections had passed 20,000 people. So far, the virus has killed 425 of these individuals, with this number now greater than the number of fatalities from the SARS virus in China. Despite this, markets are rallying higher today, following a rebound in US markets overnight.

This rally has likely been supported by the injection of Chinese stimulus into markets and their economy, but despite this, risks persist.

If history is anything to go by, markets are likely to continue seeing selling until the net new cases of the virus has peaked; which is what happened under SARS and other notable viral outbreaks.

There is also much speculation that China is either deliberately or inadvertently under-reporting the true number of infections, with The Lancet, an international medical journal, publishing a report that estimates more than 75,000 infections in Wuhan alone. They also reported that “epidemics are already growing exponentially in multiple major cities of China with a lag time behind the Wuhan outbreak of about 1–2 weeks.”

The direct impacts of the virus are already starting to be seen. Energy prices are dropping substantially due to an expected drop in travel and freight due to the virus, travel bans are likely to reduce tourism, travel, education, and perhaps even retail sales, and all of this could damage listed companies and their earnings. The Reserve Bank of Australia (RBA) went as far in its statement today as to declare that the virus is ‘having a significant effect on the Chinese economy’.

Indeed, it has been reported that China is considering lowering its economic growth targets for calendar 2020 due to the negative impacts of the virus. The RBA also warned that the ‘coronavirus outbreak will temporarily weigh on [Australian] domestic growth’.

The longer and further the virus spreads, the greater the impact on the global economy. The greater the impact on the global economy and the more sensational the media coverage, the more selling we are likely to see in global markets.

Companies that have been immediately impacted by the virus, such as travel related stocks, have already seen some serious selling, but many of these stocks have rebounded today. Regardless, prominent investors, such as former PIMCO CEO Mohamed El-Erian, have warned that the virus could shake markets out of their current ‘buy-the-dip’ mentality.

Although we have not seen real market selling for some time, it may still pay to be cautious.

  • About
  • Latest Posts
Sam Green
Sam Green is the Portfolio Manager at Emerald Financial, whilst also being an Equities and Derivatives expert for his clients at TradersCircle.
Latest posts by Sam Green (see all)
  • XJO to rise despite slight US pullback - August 30, 2024
  • Markets jump strongly higher - July 29, 2024
  • US shares drop with tech selling, XJO to continue lower - July 25, 2024
  •  
  •  
  •  
  •  
  • Opinion

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Sam Green
Sam Green is the Portfolio Manager at Emerald Financial, whilst also being an Equities and Derivatives expert for his clients at TradersCircle.
Latest posts by Sam Green (see all)
  • XJO to rise despite slight US pullback - August 30, 2024
  • Markets jump strongly higher - July 29, 2024
  • US shares drop with tech selling, XJO to continue lower - July 25, 2024

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Sam Green
Sam Green is the Portfolio Manager at Emerald Financial, whilst also being an Equities and Derivatives expert for his clients at TradersCircle.
Latest posts by Sam Green (see all)
  • XJO to rise despite slight US pullback - August 30, 2024
  • Markets jump strongly higher - July 29, 2024
  • US shares drop with tech selling, XJO to continue lower - July 25, 2024
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.